Olanzapine for Nausea/Vomiting Prophylaxis in Recipients of Hematopoietic Stem Cell Transplants
Clinical trial NCT04535141 · COMPLETED
Trial details
- NCT number
- NCT04535141
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-18
- Primary completion
- 2022-04-11
- Enrollment
- 91
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.